SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/25/16 Opexa Therapeutics, Inc. 8-K:1 11/23/16 1:28K Blueprint/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 16K
Blueprint |
Texas
|
|
|
76-0333165
|
|
(State
or other jurisdiction ofincorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
2635 Technology Forest Blvd., The Woodlands, Texas
|
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
|
|
Registrant’s
telephone number, including area code: (281) 272-9331
|
||
N/A
|
||
(Former name or
former address, if changed since last report)
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Dated:
November 25, 2016 |
OPEXA THERAPEUTICS,
INC.
|
|
|
|
|
|
|
|
By:
|
/s/
Neil K.
Warma
|
|
|
|
Neil K.
Warma
|
|
|
|
President, Chief
Executive Officer
and
Acting Chief Financial Officer
|
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 11/25/16 | |||
For Period End: | 11/23/16 | |||
10/28/16 | 8-K | |||
2/4/13 | 4, 4/A, 8-K | |||
List all Filings |